Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An ACE Inhibitor or an Angiotensin Receptor Blocker as a Treatment for Methamphetamine Dependence

NCT01062451 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT01062451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01062451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An ACE Inhibitor or an Angiotensin Receptor Blocker as a Treatment for Methamphetamine Dependence
Lead sponsor
Baylor College of Medicine
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2009
Completion date
November 20, 2013
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine abuse, methamphetamine dependence, substance abuse